Barometer Capital Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,487 shares of the pharmaceutical company’s stock after selling 3,342 shares during the period. Vertex Pharmaceuticals makes up approximately 1.2% […]
Washington Trust Bank cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the period. Vertex Pharmaceuticals comprises approximately 1.3% of Washington Trust […]
Elo Mutual Pension Insurance Co lifted its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,533 shares of the pharmaceutical company’s stock after acquiring an additional 977 shares during the […]
Stamos Capital Partners L.P. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 56.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the pharmaceutical company’s stock after selling 1,630 shares […]
Epoch Investment Partners Inc. grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 358,916 shares of the pharmaceutical company’s stock after purchasing an additional 10,059 shares during the period. Epoch […]